Michael Pachter: Netflix Faces Growth Challenges

This story from Wall Street Cheat Sheet
According to analyst Michael Pachter at Wedbush Morgan, “Netflix (NASDAQ:NFLX) will be challenged to grow at its current pace for more than another year, and we expect its premium valuation to contract.”
Here’s Pachter’s bullet points for next week’s earnings release:
- Netflix (NASDAQ:NFLX) will report its Q4 2010 (Dec) results after market close on Wednesday, January 26 with a call at 3:00pm PT (760-666-3613 or at http://ir.netflix.com).
- We expect Q4 results in-line with our estimates for revenue of $601 million and EPS of $0.75, though ending subs may be higher than our estimate of 19.7 million, compared with consensus for revenue of $597 million and EPS of $0.71.
- Increasing subscriber growth from streaming expected to drive revenue.
- Netflix should continue to benefit from brick-and-mortar store closures.
- Although Netflix should meet its Q4 EPS guidance, continued heavy spending on its streaming catalog will be a drag on margins in the long-term.
- We believe that Netflix will be challenged to grow at its current pace for more than another year, and we expect its premium valuation to contract.
- Maintaining our UNDERPERFORM rating and our 12-month price target of $78, which reflects a multiple of 21x our FY:11 EPS estimate of $3.73.
Don’t Miss: Is Netflix About to Crash? >>
Premium: Get winning investment ideas with the Wall St. Cheat Sheet Premium newsletter >>
Read more at Wall Street Cheat Sheet – The Trade
Source:
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.

